Amgen Inc. (TSX:AMGN)
29.71
-0.09 (-0.30%)
Oct 6, 2026, 3:42 PM EST
Amgen Market Cap
Amgen has a market cap or net worth of CAD 309.51 billion as of October 6, 2026. Its market cap has increased by 38.35% in one year.
Market Cap
309.51B
Enterprise Value
371.11B
Revenue
54.10B
Ranking
n/a
PE Ratio
24.93
Stock Price
29.71
ChartMarket Cap Chart
Since December 20, 1983, Amgen's market cap has increased from 89.27M to 309.51B, an increase of 346,625.31%. That is a compound annual growth rate of 20.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 309.51B | 28.08% |
| Dec 31, 2025 | 241.66B | 19.88% |
| Dec 31, 2024 | 201.59B | -0.97% |
| Dec 29, 2023 | 203.56B | 7.33% |
| Dec 30, 2022 | 189.67B | 18.28% |
| Dec 31, 2021 | 160.36B | -5.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Apotex Health | 7.14B |
| Curaleaf Holdings | 3.76B |
| Extendicare | 2.69B |
| Sienna Senior Living | 2.22B |
| Green Thumb Industries | 2.09B |
| Cronos Group | 1.70B |
| WELL Health Technologies | 1.10B |
| Knight Therapeutics | 1.01B |